The increased pancreatic cancer risk in individuals carrying the Arg399 polymorphism of XRCC1 is potentially the result of a reduced cellular capacity to repair mutations that result from oxidative DNA damage. The gene discussed is XRCC1; the disease is pancreatic neoplasm.